Balsm Alofoq Medical Company CJSC 9620.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

22.00

—

Close of 28 Oct 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 20.4m

FY2022FY2025

Net income

SAR 2.0m

FY2022FY2025

Free cash flow

−SAR 7.1m

FY2022FY2025

Shareholders' equity

SAR 30.9m

FY2022FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022
Revenue	SAR 20.4m	SAR 19.9m	SAR 18.0m	SAR 17.0m
Gross profit	SAR 7.8m	SAR 9.4m	SAR 8.0m	SAR 8.2m
Operating income	SAR 2.6m	SAR 4.7m	SAR 4.1m	SAR 3.7m
Net income	SAR 2.0m	SAR 4.8m	SAR 4.2m	SAR 3.5m
Diluted earnings per share	0.79	2.29	2.81	1.41

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022
Total assets	SAR 35.6m	SAR 33.3m	SAR 18.7m	SAR 14.9m
Cash and short-term investments	—	SAR 18.2m	SAR 3.7m	SAR 5.7m
Total liabilities	SAR 4.8m	SAR 4.4m	SAR 4.3m	SAR 7.5m
Debt	—	SAR 1.8m	SAR 1.9m	SAR 2.6m
Shareholders' equity	SAR 30.9m	SAR 28.9m	SAR 14.4m	SAR 7.4m
Shares outstanding	3m	2m	1m	3m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022
Cash from operations	−SAR 2.9m	SAR 5.5m	SAR 5.4m	SAR 4.7m
Capital spending	−SAR 4.2m	−SAR 210,710	−SAR 7.2m	−SAR 193,288
Free cash flow	−SAR 7.1m	SAR 5.3m	−SAR 1.7m	SAR 4.5m
Dividends paid	—	−SAR 3.0m	−SAR 960,300	—

Latest quarters

By quarter end

	Dec 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023
Revenue	SAR 10.6m	SAR 4.9m	SAR 4.9m	SAR 5.2m	SAR 5.2m	SAR 4.8m	SAR 4.8m	SAR 4.6m
Gross profit	SAR 3.5m	SAR 2.1m	SAR 2.1m	SAR 2.4m	SAR 2.4m	SAR 2.3m	SAR 2.3m	SAR 2.2m
Operating income	SAR 3.5m	SAR 712,806	SAR 712,806	SAR 1.6m	SAR 1.6m	SAR 752,655	SAR 752,655	SAR 1.1m
Net income	SAR 623,917	SAR 671,745	SAR 671,745	SAR 1.7m	SAR 1.7m	SAR 717,291	SAR 717,292	SAR 1.2m
Diluted earnings per share	0.25	0.27	0.27	0.80	0.80	0.34	0.34	0.82
Cash from operations	—	—	—	SAR 1.0m	SAR 1.0m	—	—	SAR 1.0m
Capital spending	—	—	—	—	—	—	—	−SAR 3.0m
Free cash flow	—	—	—	—	—	—	—	−SAR 2.0m
Total assets	SAR 35.6m	SAR 34.3m	SAR 34.3m	SAR 33.3m	SAR 33.3m	SAR 20.2m	SAR 20.2m	SAR 18.7m
Cash and short-term investments	—	SAR 18.1m	SAR 18.1m	SAR 18.2m	SAR 18.2m	SAR 5.3m	SAR 5.3m	SAR 3.7m
Debt	—	SAR 223,736	SAR 223,736	SAR 308,482	SAR 308,482	SAR 313,891	SAR 313,891	SAR 469,880
Shareholders' equity	SAR 30.9m	SAR 30.3m	SAR 30.3m	SAR 28.9m	SAR 28.9m	SAR 15.8m	SAR 15.8m	SAR 14.4m

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	6.2%	—	—
Operating income	-11.7%	—	—
Net income	-17.6%	—	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	42.7%	44.3%	—	—

Valuation history

At each fiscal year end

	FY2025	FY2024
Price to earnings	34.6	16.1
Price to sales	3.3	3.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

2-for-1 split · 22 Dec 2025

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Balsm Alofoq Medical Company CJSC 9620.SR · SAR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology